This week in transparency news: April 27 – May 3, 2019

by Staff writer,
Posted on 5/3/2019

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

European universities fail to report results for 83% of trials – FierceBiotech

A major registry analysis revealed that 83% of European universities fail to report clinical trial results. In 2014, the EU began requiring sponsors to register clinical trials and post results within 12 months of completing the study, but many universities have yet to comply.

Nick Paul Taylor has the full story here

Transparency in clinical trials: data, safety and monitoring of cancer patients Patient Power

James Omel, MD; Mike Thompson, MD, PhD, FASCO; and Andrew Schorr discuss data transparency in clinical research. They describe the care cancer patients receive in clinical trials, challenges inherent to clinical trials, and how Data, Safety, and Monitoring Boards (DSMB), Institutional Review Boards (IRB), and ClinicalTrials.gov registration work to safeguard participants.

Watch the Patient Power video

The new clinical trial regulation: overview and impact – Yahoo! Finance

ResearchAndMarkets.com just added the “New Clinical Trial Regulation: Overview and Impact” conference to its course offerings. The course will provide an essential understanding of EU Clinical Trial Regulation (536/2014) and help sponsors comply with the law.

Read the press release

Why wearables, health records and clinical trials need a blockchain injection Computerworld

Computerworld Senior Reporter Lucas Mearian writes that the future of healthcare could rely on the open transmission of patient data, with blockchain acting as the conduit. Patients could sell their anonymized data in the future, as the patient information industry continually grows.

Read the full article by Lucas Mearian here

Share: